Medpace Holdings financials
$622.11+1.00%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.11B | $1.89B | $1.46B | $1.14B | $925.9M | $861.0M | $704.6M | $436.2M | $421.6M |
| Gross profit | $760.6M | $656.3M | $524.5M | $1.46B | $1.14B | $925.9M | $861.0M | $704.6M | $224.4M | $223.1M |
| Gross margin | 30.1% | 31.1% | 27.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 51.4% | 52.9% |
| Operating income | $534.9M | $446.9M | $336.8M | $278.7M | $198.6M | $167.0M | $127.3M | $101.0M | $64.9M | $52.5M |
| Net income | $451.1M | $404.4M | $282.8M | $245.4M | $181.8M | $144.9M | $100.2M | $72.9M | $39.1M | $13.4M |
| Net margin | 17.8% | 19.2% | 15.0% | 16.8% | 15.9% | 15.7% | 11.6% | 10.3% | 9.0% | 3.2% |
| Diluted EPS | $15.28 | $12.63 | $8.88 | $7.28 | $4.81 | $3.84 | $2.67 | $1.97 | $0.98 | $0.37 |
| EBITDA | $563.1M | $476.1M | $363.2M | $301.0M | $219.7M | $186.6M | $150.5M | $139.8M | $111.3M | $110.6M |
| Operating cash flow | $713.2M | $608.8M | $433.4M | $388.1M | $263.3M | $258.7M | $201.9M | $156.6M | $97.4M | $91.7M |
| Free cash flow | $681.9M | $572.3M | $396.7M | $351.2M | $235.1M | $227.3M | $184.0M | $140.6M | $85.7M | $78.2M |
| Diluted shares | 29.5M | 32.0M | 31.8M | 33.7M | 37.7M | 37.7M | 37.6M | 36.9M | 39.8M | 36.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $497.0M | $669.4M | $245.4M | $28.3M | $461.3M | $277.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $50.0M | $0.00 | $0.00 |
| Total assets | $1.98B | $2.10B | $1.66B | $1.35B | $1.66B | $1.39B |
| Total liabilities | $1.52B | $1.28B | $1.10B | $966.1M | $707.0M | $584.9M |
| Shareholders' equity | $459.1M | $825.5M | $559.0M | $386.4M | $952.9M | $805.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology